- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Mitrovic B, Gluvic Z, Klisic A, Obradovic M, Macut D, Tomasevic R, Isenovic ER
A Non-Invasive Method for Estimating the Severity of Liver Steatosis and the Risk of Fibrosis in Non-Obese Type 2 Diabetes Patients with NAFLD
Acta Endo (Buc) 2022, 18 (4): 480-487doi: 10.4183/aeb.2022.480
Context. Prognostic considerations include
assessing the risk of liver fibrosis in people with nonalcoholic
fatty liver disease (NAFLD).
Objectives. This study evaluates the use of
hematologic and metabolic parameters regarding liver
steatosis and fibrosis scores (FLI and Fib-4) in non-obese
type 2 diabetes mellitus (t2DM) patients with NAFLD.
Methods. Subjects underwent abdominal
ultrasound examinations, and FLI and Fib-4 scores were
calculated to evaluate liver steatosis and the risk of liver
fibrosis non-invasively: 61 non-obese NAFLD subjects with
t2DM were included in the cohort study and were divided
into 2 groups depending on the t2DM treatment regimen.
Results. Fib-4 and WBC count demonstrated
a significant inverse correlation (OR = 0.509, p = 0.007).
WBC count had an R2 of 0.237, indicating that this marker
could account for up to 23.7% of a variation in Fib-4. Fib-
4 and FFA had positive correlation which did not achieve
statistically significant prediction (OR=7.122, p=0.062).
Additionally, a significant prediction of HbA1c (OR=1.536,
p=0.016) and haemoglobin (OR=1.071, p=0.020) for FLI
was revealed.
Conclusion. HbA1c and other haematological and
metabolic parameters, such as haemoglobin and WBC, may
be another non-invasive tool for determining whether nonobese
NAFLD patients with t2DM are at risk of developing
liver steatosis and fibrosis.
Keywords: liver fibrosis, liver biopsy, Fib-4, FLI score, NAFLD, t2DM.
Correspondence: Milan Obradovic MD, VINCA Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of
Belgrade, Dept. of Radiobiology and Molecular Genetics, Mike Petrovica Alasa 12-14, Belgrade, Serbia, 11000, E-mail: obradovicmilan@hotmail.com